Drugs in R and D : Impact Factor & More
eISSN: 1179-6901pISSN: 1174-5886
Open AccessShare this on:
Key Metrics
CiteScore 
4.3
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.95
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Drugs in R and D
Drugs in R and D Journal Specifications
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2690 | USD 3390 | GBP 2290 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Drugs in R and D ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drugs in R and D
Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial.
- 24 Nov 2025
- Drugs in R&D
Bioequivalence of Two Perampanel Oral Suspension Formulations in Healthy Subjects: A Randomized Crossover Study.
- 18 Nov 2025
- Drugs in R&D
Efficacy and Safety of Ulinastatin in Post-traumatic Sepsis: A Randomized Controlled Trial.
- 5 Nov 2025
- Drugs in R&D
Bioequivalence Study of Bedaquiline and Sirturo® in Healthy Chinese Subjects Under Fasting and Postprandial Conditions: A Randomized, Open-Label, Single-Dose, Crossover Trial.
- 31 Oct 2025
- Drugs in R&D
Establishment of a Vancomycin Population Pharmacokinetic Model for Pediatric Patients Based on the Non-Linear Mixed-Effects Model.
- 24 Sep 2025
- Drugs in R&D
Bioequivalence Study of Two Formulations of Flunarizine Hydrochloride Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
- 1 Sep 2025
- Drugs in R&D
Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial.
- 24 Nov 2025
- Drugs in R&D
Bioequivalence of Two Perampanel Oral Suspension Formulations in Healthy Subjects: A Randomized Crossover Study.
- 18 Nov 2025
- Drugs in R&D
Efficacy and Safety of Ulinastatin in Post-traumatic Sepsis: A Randomized Controlled Trial.
- 5 Nov 2025
- Drugs in R&D
Bioequivalence Study of Bedaquiline and Sirturo® in Healthy Chinese Subjects Under Fasting and Postprandial Conditions: A Randomized, Open-Label, Single-Dose, Crossover Trial.
- 31 Oct 2025
- Drugs in R&D
Establishment of a Vancomycin Population Pharmacokinetic Model for Pediatric Patients Based on the Non-Linear Mixed-Effects Model.
- 24 Sep 2025
- Drugs in R&D
Bioequivalence Study of Two Formulations of Flunarizine Hydrochloride Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
- 1 Sep 2025
- Drugs in R&D
FAQs on Drugs in R and D
How long has Drugs in R and D been actively publishing? 
What is the publishing frequency of Drugs in R and D?
How many articles did Drugs in R and D publish last year?
What is the eISSN & pISSN for Drugs in R and D?
What is Citescore for Drugs in R and D?
What is SNIP score for Drugs in R and D?
What is the SJR for Drugs in R and D?
Who is the publisher of Drugs in R and D?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations